Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial.
Journal: Current medical research and opinion
Published: July 11, 2026
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 12, 2026
Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.
Journal: Journal of endocrinological investigation
Published: January 24, 2026
Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.
Journal: Journal of endocrinological investigation
Published: January 19, 2026
Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
Journal: The American journal of medicine
Published: December 22, 2025
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.
Journal: Diabetes, obesity & metabolism
Published: October 31, 2025
Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study.
Journal: Journal of endocrinological investigation
Published: October 20, 2025
Health state utilities associated with obstructive sleep apnea: preferences of patients with OSA and obesity in the UK and the US.
Journal: Journal of medical economics
Published: October 15, 2025
Overcoming weight bias in health care systems.
Journal: The American journal of managed care
Published: September 18, 2025
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial.
Journal: Diabetes, obesity & metabolism
Published: September 05, 2025
Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial.
Journal: European heart journal open
Published: July 22, 2025
Insights into the Mechanism of Action of Tirzepatide: A Narrative Review.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 24, 2025
Last Updated: 09/26/2026